MD,Chief Physician, Vice President at Kidney Disease Center, the First Affiliated Hospital, School of Medicine, Zhejiang University, China
Dr. Chen DaJin is a distinguished physician-scientist with an MD and PhD, serving as Chief Physician and Doctoral Supervisor at the First Affiliated Hospital of Zhejiang University School of Medicine. As Deputy President of the hospital, he holds influential roles across national and international medical organizations, including the Asia-Pacific Society of Nephrology and Chinese Medical Associations. He is well-regarded for his leadership in nephrology, particularly in chronic kidney disease and kidney transplantation. With over 40 publications, 13 patents (including one U.S. patent), and multiple national-level research projects under his belt, Dr. Chen has made substantial contributions to clinical medicine and medical innovation. His work has been recognized with multiple awards and civic honors, including “Top Ten Outstanding Young People of Hangzhou.” Known for blending clinical excellence with academic rigor, Dr. Chen is a key figure in advancing precision medicine and organ transplantation in China and beyond. 🌍📚🧠
Professional Profiles
Scopus
🎓 Education
Dr. Chen DaJin pursued his medical degree (MD) followed by a Doctorate in Medicine (PhD) with a specialization in nephrology. His academic journey has been rooted in Zhejiang University, one of China’s top-tier medical institutions. Throughout his training, he demonstrated a strong commitment to both clinical proficiency and research innovation, contributing early to kidney disease and transplant research. His postgraduate studies emphasized evidence-based medicine, biomedical engineering, and organ transplantation technologies. He continued to enrich his academic foundation with international exposure, participating in conferences and collaborative research efforts across Asia and North America. Dr. Chen’s educational philosophy blends traditional Chinese medical values with modern scientific advancemens, making him a forward-thinking clinician and scholar. His dual-degree background enables him to bridge the gap between bedside care and bench-side research. 🎓🧬🔬
🧪 Experience
Dr. Chen DaJin brings over 15 years of clinical and academic experience in internal medicine, nephrology, and transplantation. He currently serves as Deputy President of the First Affiliated Hospital of Zhejiang University School of Medicine and as Chief Physician and Doctoral Supervisor. He leads high-stakes clinical teams in kidney transplantation and manages national-level research projects. In parallel, he holds leadership positions in over ten professional societies, including the Asia-Pacific Society of Nephrology and the Chinese Society of Precision Medicine. He has supervised numerous PhD students and young physicians, promoting knowledge translation from lab to clinic. His work spans policy consultation, health economics, and organ transplantation ethics. Dr. Chen is also actively involved in medical education reform, fostering a culture of clinical research and precision medicine in Zhejiang Province. 🏥🔍📈
🏅 Awards and Honors
Dr. Chen DaJin has earned widespread recognition for his scientific contributions and public service. Notably, he received the Outstanding Paper Award at the 2014 American Society of Nephrology Annual Meeting and the Excellent Paper Award at the 2015 Chinese Society of Nephrology Conference. He has also been honored as one of the “New Era Hangzhou Top Ten Outstanding Young People” and named a “Zhejiang Province Volunteer Service Advanced Worker”. His title as a “Zhejiang University Young Post Expert” highlights his academic leadership and mentorship. Dr. Chen’s accolades reflect his commitment to clinical excellence, research innovation, and community engagement. These awards affirm not only his individual accomplishments but also his impact on China’s nephrology landscape and beyond. 🥇📜💡
🔬 Research Focus
Dr. Chen DaJin’s research is primarily focused on chronic kidney disease (CKD), kidney transplantation, and dialysis innovation. His projects target the early diagnosis, immune regulation, and long-term graft survival in renal transplant patients. He has led 11 major funded projects, including grants from the National Natural Science Foundation of China and the Zhejiang Provincial Research Program. His work also explores biomaterials, genetic markers, and AI-driven diagnostic tools in nephrology. With over 40 academic publications, Dr. Chen emphasizes translational research that bridges clinical practice with emerging biomedical technology. His 13 patents—one granted in the U.S.—demonstrate a strong commitment to practical innovation. He aims to improve patient outcomes and reduce complications in long-term renal care. 🧪🧠🧫
🛠️ Research Skills
Dr. Chen DaJin is proficient in a diverse range of clinical and scientific skills. Clinically, he excels in renal replacement therapy, dialysis management, and organ transplantation surgery. Scientifically, he is skilled in molecular diagnostics, clinical trial design, biostatistics, and evidence-based medicine. As a mentor, he offers guidance in academic writing, grant proposal development, and research methodology. His leadership and administrative skills enable him to manage large-scale clinical teams and multi-institutional research projects. He is also adept in medical ethics, health policy formulation, and cross-disciplinary collaboration. His technological proficiency includes use of clinical data platforms, EMR analytics, and medical AI systems. Dr. Chen’s unique blend of hands-on clinical expertise and strategic research insight positions him as a visionary leader in modern nephrology. 💻🧑🔬🩺
✅ Conclusion
Dr. Chen DaJin is a highly qualified candidate for the Best Research Article Award, particularly if the nomination is anchored in a specific, recent, and impactful publication. His exceptional research credentials, clinical focus, and innovation footprint mark him as a leader in nephrology and transplantation science. Provided that the article in question meets the criteria for originality, impact, and scientific rigor, he would be a strong and deserving contender for the award.
Publications Top Notes
Title: Therapeutic potential of p-coumaric acid in alleviating renal fibrosis through inhibition of M2 macrophage infiltration and cellular communication
Authors: Qinfan Yao, Xinyi Zhang, Lefeng Wang, Jianghua Chen, Dajin Chen
Year: 2025
Citations: 0
Title: METTL3 potentiates M2 macrophage-driven MMT to aggravate renal allograft fibrosis via the TGF-β1/Smad3 pathway
Authors: Qinfan Yao, Xiaoxiao Zheng, Xinyi Zhang, Jianghua Chen, Dajin Chen
Year: 2025
Citations: 1